Investing Profile

Graeme R. Martin

InvestorVC
Principal at HatchBox Bioconsulting LLC
alsaventures.comSan Francisco Bay Area
Photo of Graeme R. Martin, Principal at HatchBox Bioconsulting LLC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
UCL Network
104 CONNECTIONS
Roche Network
31 CONNECTIONS
University of Bath Network
21 CONNECTIONS
cb
$100K - $5.0M
$1.5M
12
CompanyStageDateRound SizeTotal Raised
Univercells
Series UnknownOct 2015$3M
$3M
Presage Biosciences
Series UnknownAug 2015
Co-investors: David Wu (Maveron)
Naurex
Series CDec 2014$80M
Series AMay 2011$18M
$98M
Heptares Therapeutics
Series BJun 2013$21M
$21M
ArmaGen Technologies
Series ANov 2012$17M
$17M
Co-investors: Martin Heidecker (Hotmail)
Redwood Bioscience
Series UnknownJun 2011
Serenex
Series DJun 2007$26M
Series COct 2005$30M
Series UnknownJul 2004$8M
$79M
Co-investors: Garheng Kong (HealthQuest Capital)
Lectus Therapeutics
Series AFeb 2006$14M
$14M
Co-investors: Antoine Papiernik Papiernik (Sofinnova Partners)
Vice President, CNS Therapeutic Area RochePresent
Principal HatchBox Bioconsulting LLCPresent
Non Executive Director 3Brain AGPresent
Non Executive Director Scioto Biosciences, IncPresent
Chairperson DJS AntibodiesPresent
Non Executive Director ARJUNA TherapeuticsPresent
Harrington Discovery Institute Investment Advisor Harrington Discovery Institute at University HospitalsPresent
Chief Investment Officer ALSA VenturesPresent
Non Executive Director Montis BiosciencesPresent
Member Of The Board Of Advisors BioneexPresent
Board Member / Consultant ALSA VenturesPresent
Non Executive Director Vantage BiosciencesPresent
Executive Chairperson Promatix Biosciences LtdPresent
President & CEO Takeda Ventures, Inc.Present
University of Bath B.Sc. Hons Pharmacology
UCL B.Sc. Hons Pharmacology